Bosseboeuf, E;
Chikh, A;
Chaker, AB;
Mitchell, TP;
Vignaraja, D;
Rajendrakumar, R;
Khambata, RS;
Nightingale, TD;
Mason, JC;
Randi, AM;
et al.
Bosseboeuf, E; Chikh, A; Chaker, AB; Mitchell, TP; Vignaraja, D; Rajendrakumar, R; Khambata, RS; Nightingale, TD; Mason, JC; Randi, AM; Ahluwalia, A; Raimondi, C
(2023)
Neuropilin-1 interacts with VE-cadherin and TGFBR2 to stabilize adherens junctions and prevent activation of endothelium under flow.
Sci Signal, 16 (786).
ISSN 1937-9145
https://doi.org/10.1126/scisignal.abo4863
SGUL Authors: Chikh, Anissa
Microsoft Word (.docx)
Accepted Version
Available under License ["licenses_description_publisher" not defined]. Download (10MB) |
Abstract
Linear and disturbed flow differentially regulate gene expression, with disturbed flow priming endothelial cells (ECs) for a proinflammatory, atheroprone expression profile and phenotype. Here, we investigated the role of the transmembrane protein neuropilin-1 (NRP1) in ECs exposed to flow using cultured ECs, mice with an endothelium-specific knockout of NRP1, and a mouse model of atherosclerosis. We demonstrated that NRP1 was a constituent of adherens junctions that interacted with VE-cadherin and promoted its association with p120 catenin, stabilizing adherens junctions and inducing cytoskeletal remodeling in alignment with the direction of flow. We also showed that NRP1 interacted with transforming growth factor-β (TGF-β) receptor II (TGFBR2) and reduced the plasma membrane localization of TGFBR2 and TGF-β signaling. NRP1 knockdown increased the abundance of proinflammatory cytokines and adhesion molecules, resulting in increased leukocyte rolling and atherosclerotic plaque size. These findings describe a role for NRP1 in promoting endothelial function and reveal a mechanism by which NRP1 reduction in ECs may contribute to vascular disease by modulating adherens junction signaling and promoting TGF-β signaling and inflammation.
Item Type: | Article | ||||||
---|---|---|---|---|---|---|---|
Additional Information: | This is the author’s version of the work. It is posted here by permission of the AAAS for personal use, not for redistribution. The definitive version was published in Science Signaling in Vol 16, Issue 786 23 May 2023, DOI: 10.1126/scisignal.abo4863 | ||||||
Keywords: | 0601 Biochemistry and Cell Biology | ||||||
SGUL Research Institute / Research Centre: | Academic Structure > Molecular and Clinical Sciences Research Institute (MCS) | ||||||
Journal or Publication Title: | Sci Signal | ||||||
Article Number: | eabo4863 | ||||||
ISSN: | 1937-9145 | ||||||
Language: | eng | ||||||
Dates: |
|
||||||
Publisher License: | Publisher's own licence | ||||||
PubMed ID: | 37220183 | ||||||
Go to PubMed abstract | |||||||
URI: | https://openaccess.sgul.ac.uk/id/eprint/115441 | ||||||
Publisher's version: | https://doi.org/10.1126/scisignal.abo4863 |
Statistics
Actions (login required)
Edit Item |